Cite
Sheth H, Northwood E, Elliott F, et al. Point of care testing for improving risk- benefit ratio of aspirin and warfarin. Mol Cytogenet. 2014;7:I54doi: 10.1186/1755-8166-7-S1-I54.
Sheth, H., Northwood, E., Elliott, F., Jackson, M., Koref, M. S., Tyson, J., Daly, A., O'Halloran, J., Sheth, J., Sheth, F., Parikh, K., Bishop, D. T., & Burn, J. (2014). Point of care testing for improving risk- benefit ratio of aspirin and warfarin. Molecular cytogenetics, 7I54. https://doi.org/10.1186/1755-8166-7-S1-I54
Sheth, Harsh, et al. "Point of care testing for improving risk- benefit ratio of aspirin and warfarin." Molecular cytogenetics vol. 7 (2014): I54. doi: https://doi.org/10.1186/1755-8166-7-S1-I54
Sheth H, Northwood E, Elliott F, Jackson M, Koref MS, Tyson J, Daly A, O'Halloran J, Sheth J, Sheth F, Parikh K, Bishop DT, Burn J. Point of care testing for improving risk- benefit ratio of aspirin and warfarin. Mol Cytogenet. 2014 Jan 21;7:I54. doi: 10.1186/1755-8166-7-S1-I54. eCollection 2014. PMID: 24949102; PMCID: PMC4044298.
Copy
Download .nbib